Using genotyping and tissue-specific expression data from the Genotype-Tissue Expression project, researchers characterized Neanderthal allele-specific expression.
The company said that it can distinguish patients suffering from lupus from those with other autoimmune diseases using its antibody array platform.
In PLOS this week: methylation in human gametes, microRNAs linked to kidney damage in lupus patients, and more.
The company said this study marks the first time circulating RNA has been concretely linked to IFN dysregulation in lupus patients.
The firm is investing in studies that use its multiplex microarray platform to monitor lupus disease activity and traumatic brain injury response.
The firm is developing tests based on its microarray technology, which is capable of printing multiple types of biomarkers.
The meta-analysis drew on studies conducted in both European and Chinese populations, and hinted at why lupus may be more common among East Asians.
IQuity's current tests analyze gene expression patterns detected in mRNA, but the firm is also exploring the diagnostic potential of long non-coding RNAs.
The company, which also raised $14 million in a Series A round, plans to use the proceeds to commercialize panels of tests for autoimmune diseases.
The Swedish firm, a spinout of Lund University, will evaluate the array-based blood tests to confirm, rule out, and monitor the autoimmune disease.
A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.
Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.
Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.
In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.